Effect of Bushenhuoxue formula on interleukin-1 beta and discoidin domain receptor 2 levels in a rat model of osteoarthritis  by Nianhu, Li et al.
TOPIC
JTCM |www. journaltcm. com April 15, 2015 |Volume 35 | Issue 2 |
Online Submissions: http://www.journaltcm.com J Tradit Chin Med 2015 April 15; 35(2): 192-196
info@journaltcm.com ISSN 0255-2922
© 2015 JTCM. All rights reserved.
EXPERIMENTAL STUDY
Effect of Bushenhuoxue formula on interleukin-1 beta and discoidin
domain receptor 2 levels in a rat model of osteoarthritis
Li Nianhu, Xia Lei, Yi Sheng, Yu Jianhui, Zhai Yi, Xu Zhanwang
aa
Li Nianhu, Zhai Yi, Xu Zhanwang, Department of Orthope-
dics, the Affiliated Hospital of Shandong University of Tradi-
tional Chinese Medicine, Jinan 250014, China
Xia Lei, Department of Pathology, Shandong University of
Traditional Chinese Medicine, Jinan 250355, China
Yi Sheng, Department of Orthopedics, Traditional Chinese
Medicine Hospital of Shouguang City, Shouguang 262700,
China
Yu Jianhui, Department of Orthopedics, Beihai Hospital of
Yantai City, Yantai 265701, China
Supported by the Shandong Provincial Department of Edu-
cation (Mechanism of Bushenhuoxue Formula Protecting
Chondrocytes of Osteoarthritis, No. J07YD08) and the Shan-
dong Provincial Administration of Traditional Chinese Medi-
cine (Relationship between Bushenhuoxue Formula and the
Osteoarthritis Signaling Molecule DDR2, No. 2007-027)
Correspondence to: Prof. Xu Zhanwang, Department of
Orthopedics, Affiliated Hospital of Shandong University of
Traditional Chinese Medicine, Jinan 250355, China.
xzw6001@163.com
Telephone: +86-531-6861-7065, 7089, +86-13031724589
Accepted: April 19, 2014
Abstract
OBJECTIVE: To determine the effects of Bushen-
huoxue formula (BHF) on interleukin-1 beta (IL-1β),
transforming growth factor beta 1 (TGF-β1), discoi-
din domain receptor 2 (DDR2) and matrix metallo-
proteinase-1 (MMP-1) levels in a rat model of osteo-
arthritis (OA).
METHODS: Sprague-Dawley rats were used to es-
tablish an OA model and subjected to various treat-
ments over 6 weeks. Rats were treated with BHF,
glucosamine sulfate (GS), or starch as a control. Se-
rum levels of IL-1β and MMP-1 and joint fluid levels
of IL-1β were determined by means of ELISAs. We
used immunohistochemistry to determine DDR2
levels in knee cartilage. Gene expression levels of
MMP-1 in joint synovial tissue were assessed using
reverse transcription polymerase chain reaction as-
says.
RESULTS: Serum IL-1β levels were unchanged
throughout the study. Levels of IL-1β in joint fluid
and MMP-1 in sera from the BHF- and GS-treated
groups were significantly reduced. DDR2 levels in
knee cartilage were also significantly reduced in
the BHF group. Expression of the MMP-1 gene was
significantly reduced by BHF treatment.
CONCLUSION: BHF might be beneficial in the inhi-
bition and alleviation of local inflammatory re-
sponses and cartilage degeneration in OA.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Osteoarthritis (OA) is a degenerative disease; its main
pathologic findings are denatured and damaged joint
cartilage, accompanied by osteophyte formation, syno-
vitis, and narrowing of the joint space.1 OA is the re-
sult of an imbalance in factors between degradation
and synthesis of the cartilage matrix.2
In Traditional Chinese Medicine (TCM), Bushenhuox-
ue formula (BHF) is able to increase the available ener-
gy of the kidney and activate blood circulation. It is
prescribed clinically for the treatment of OA at early
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and moderate stages of the disease and is effective in
88.9% of cases. The therapeutic efficacy of BHF has
been summarized previously.3 The molecular mecha-
nisms involved in the inhibition of tumor necrosis fac-
tor-α (TNF-α) and interleukin-1 beta (IL-1β) expres-
sion in synoviocytes has been partially elucidated.4
Based on these previous results, we conducted experi-
ments to determine the influence of BHF on the ex-
pression of IL-1β, matrix metalloproteinase-1
(MMP-1) and discoidin domain receptor 2 (DDR2)
which is signaling molecules of OA.
MATERIALS ANDMETHODS
Rat model of OA
We used 56 (28 male, 28 female) specific patho-
gen-free Sprague-Dawley rats that were (250 ± 20) g
and 3 months old. Rats were raised in the animal cen-
ter at Shandong University of Traditional Chinese Med-
icine (Quality Certificate No. SCXK [Lu] 20050015).
All animal procedures were performed in accordance
with Shandong University's ethical principles for the
care and use of laboratory animals.
All rats underwent identical surgeries; a longitudinal in-
cision was made on the medial side of the right hind
knee. The medial collateral ligament was transected
and the medial meniscus was cut through.5 Damage to
the articular cartilage was avoided during surgery. The
wound was cleaned and rinsed with phosphate-buff-
ered saline (PBS) containing 50 mg/kg ampicillin to
prevent local infection. Animals were fed a normal diet
over the 6-week period of our study.
Treatment groups
Five rats were randomly selected to verify the establish-
ment of the OA model. Of the remaining rats, 33 were
chosen and randomly allocated to three groups (n = 11
rats per group): the BHF treatment group; the glucos-
amine sulfate (GS) treatment group; and the control
group. Equal volumes of a concentrated BHF decoc-
tion were gavaged or orally administered to rats in the
BHF group twice a day. A powder suspension of GS
was given to animals in the GS group, and a starch sus-
pension was given to rats in the control group. The
treatment period was 6 weeks. We collected tissue sam-
ples from animals prior to establishment of the OA
model and after the treatment period. Tissue sections
were stained with hematoxylin-eosin (HE) and then ex-
amined microscopically.
Dosage conversion
The BHF decoction comprised Fuzi (Radix Aconiti
Lateralis Preparata) 10 g, Dihuang (Radix Rehmanniae)
20 g, Danshen (Radix Salviae Miltiorrhizae) 20 g, Baji-
tian (Radix Morindae Officinalis) 15 g and Xianmao
(Rhizoma Curculiginis) 10 g. All components were re-
fined granules from the Chinese herbal pieces (Cat. #
0905261s; 999 Pharmacological Company, Shenzhen,
China). Granules were dissolved in 66.67 mL of water
at 100 ℃ and then kept at room temperature until re-
quired. We purchased GS from Zhejiang Hisun Phar-
maceutical Co., Ltd., (Cat. # 09051701, Zhejiang,
China).
Equivalent surface area dose conversion factors for hu-
mans and rats were used to determine the appropriate
dose for rats.6 We used the following formula:
Drug dose for human (mg/kg) × 0.47 (rat body surface
area ratio) / 0.08 (human body surface area ratio) = re-
quired drug dose for rats (mg/kg)
Based on a clinical regimen of 500 mg three times a
day for GS, and 150 mL of the BHF decoction twice a
day for a 50-kg adult human, the dose for a 250-g rat
was determined to be 44 mg of GS and 9 mL of the
BHF decoction per day. The optimal gavage volume is
2 mL for a rat. A 2-mL suspension contained 22 mg of
GS, or a 2-mL concentrated BHF decoction derived
from a 4.5-mL BHF decoction. Suspensions were giv-
en to rats twice a day.
Measurement of IL-1β levels
Blood samples were collected 1 h after the last oral ad-
ministration of GS, BHF or starch for the determina-
tion of IL-1β levels in serum. Synovial fluid was ex-
tracted from the right hind knee joint following the in-
jection of 200 μL saline at the termination of the ex-
periment.7 Animal were sacrificed by suffocation in
CO2 box. Cytokine levels were determined using en-
zyme-linked immunosorbent assays (ELISAs).
Immunohistochemistry
For immunohistochemical staining, rat knee joints
were harvested at the end of our study. Tissue sections
were deparaffinized, hydrated, and quenched for en-
dogenous peroxidase activity. After treatment with
chondroitinase ABC (1∶200 dilution; Sigma-Aldrich,
St Louis, MO, USA), sections were incubated with an
anti-DDR2 polyclonal antibody (1∶200; Abcam, Cam-
bridge, MA, USA). After washing with PBS (Sigma-Al-
drich), samples were incubated with a biotinylated sec-
ondary antibody (Vectastain ABC kit; Vector Laborato-
ries, Burlingame, CA, USA). We used Image-Pro Plus
6.0 (Media Cybernetics, Silver Spring, MD, USA) to
analyze images. Ten fields of view were selected for
each sample, and positive areas accumulated and aver-
aged. The mean optical density (MOD) and integrated
optical density (IOD) were calculated and IOD values
were subjected to statistical tests.
Reverse transcription polymerase chain reaction
(RT-PCR) assays
We used RT-PCR assays to determine MMP-1 mRNA
expression levels in joint synovial tissues. We extracted
RNA from homogenized joint synovial tissue. Reverse
transcription was performed using 2 µg of total RNA
and random primers. The resulting cDNA was ampli-
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fied over 33 cycles with two specific oligonucleotide
primers (5′-ACA GTT TCC CCG TGT TTC AG-3′
and 5′-CCC ACA CCT AGG TTT CCT CA-3′ ).
Each cycle involved denaturation at 94 ℃ for 30 s, an-
nealing at 55 ℃ for 30 s, and a 1-min extension step at
68 ℃ (StepOnePlus ™, Life Technologies, Carlsbad,
CA, USA). Amplicons were electrophoresed on 2% (w/
v) agarose gels and stained with ethidium bromide.
Measurement of MMP-1
MMP-1 levels were determined using ELISAs. Synovi-
al fluid was extracted from the right hind knee joint fol-
lowing the injection of 200 µL of saline at the termina-
tion of our study. Synovial fluid samples were diluted (1
∶4) with assay buffer; 100 μL of diluted samples and
standards were added to the wells of a microtiter plate
pre-coated with an MMP-1 antibody. The plate was in-
cubated at room temperature for 2 h. After five wash-
ing steps with wash buffer to remove unbound antigen,
secondary antibodies conjugated to peroxidase were
added. Following a wash to remove any unbound anti-
body-enzyme reagent, a substrate solution was added.
The color reaction was stopped by the addition of an
acid solution and plates read at 450 nm in an EC 312
microplate reader (SpectraMax Plus384, Molecular De-
vices, Sunnyvale, CA, USA). The concentration of
MMP-1 in a sample was determined by interpolation
from a standard curve.
Statistical analyses
We used SPSS 17.0 (SPSS Inc., Chicago, IL, USA) for
all statistical analyses. Values were expressed as mean ±
standard deviation ( xˉ ± s ). A one-way analysis of vari-
ance was used to determine the difference among
groups. A P-value less than 0.05 was deemed statistical-
ly significant.
RESULTS
Establishment of a rat OA model and pathological
analysis
We randomly selected five rats 6 weeks after surgery to
evaluate our OA model. Following euthanasia of these
rats, right hind knee joints were dissected. The femur
and tibial plateau articular surfaces were collected for
morphological examination. Macroscopic observations
revealed marked articular damage. Microscopic exami-
nation of HE-stained sections were performed; com-
pared with normal joints (Figure 1A), the menis-
cus-rupture model exhibited reduced articular cartilage
thickness, roughness of the cartilage surface, a decrease
in cartilage cells counts, subchondral osteoporosis, and
micro fractures (Figure 1B). Changes were observed be-
tween the BHF and control groups. The cartilage was
thinner and in some cases ruptured in the control
group (Figure 1D). The integrity of cartilage was main-
tained in the BHF group even though cartilage cells
had degenerated (Figure 1C).
IL-1β in serum and synovial fluid
IL-1β levels in synovial joint fluid were significantly re-
duced after treatment with BHF or GS in comparison
with those seen for the control group (P < 0.05). We
did not observe a significant difference in IL-1β levels
in serum samples from the three treatment groups
(Table 1).
Immunohistochemical analysis of DDR2 levels in
cartilage
We detected DDR2 in cartilage sections using immu-
nohistochemical methods (Figure 2A). Reduced expres-
sion of DDR2 was obvious in the BHF group (Figure
2B). Quantitation of DDR2 expression by IOD
showed a significant difference between the BHF and
control groups (P < 0.05; Table 1). WE failed to ob-
serve statistical differences between the BHF and GS
groups, or between the GS and control groups (P <
0.05).
MMP-1 expression in synovial tissue
MMP-1 expression in synovial tissue was significantly
A B
C D
Figure 1 Morphological examination of tissue sections from
a rat OA model (HE staining, ×40)
A: microscopic examination of HE-stained sections of nor-
mal joint; B: microscopic examination of HE-stained sections
of degenerated joint, reduced articular cartilage thickness,
roughness of the cartilage surface, a decrease in cartilage
cells counts, subchondral osteoporosis, and micro fractures
could be seen (arrow); C: the integrity of cartilage was main-
tained in the Bushenhuoxue Formula group; D: the cartilage
was thinner and ruptured in the control group; OA: osteoar-
thritis; HE: haematoxylin-eosin.
Figure 2 Immunohistochemical detection of DDR2 in carti-
lage (Immunohistochemical staining, ×10)
A: immunohistochemical staining of control tissue; B: re-
duced expression of DDR2 was seen in samples from the
Bushenhuoxue formula group with immunohistochemical
staining. Brown staining is indicative of a positive signal.
DDR2: discoidin domain receptor 2.
BA
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reduced in samples from the BHF-treated group, and
slightly reduced in the GS group when compared with
levels in the control group (Figure 3).
MMP-1 levels in synovial fluid
The levels of MMP-1 in synovial joint fluid were signif-
icantly reduced following treatment with BHF or GS
when compared with those in the control group (P <
0.05; Table 1).
DISCUSSION
Based on TCM theory and our practical experiences,
OA pathogenesis of the knee primarily involves kidney
deficiency, followed by blood stasis. The Bushenhuox-
ue formula was made to treat these symptoms. Aconite
enforces the kidney Yang and releases coldness and re-
lieves pain. Rehmannia tonifies blood and kidney Yin,
as well as bone marrow. The spicy divergent characteris-
tics of aconite mean that Rehmannia's tonification is
not stagnated. The greasy characteristics of Rehmannia
can reduce the dry nature of aconite, ensuring that
tonification is not aggressive. A deficiency in kidney
Yin and Yang could be evenly tonified with a combina-
tion of the two herbs. Salvia was used to promote
blood circulation, soothe the nerves, and eliminate car-
buncles so swelling and pain in the knee can be re-
lieved. Morinda and Curculigo warms the kidney,
strengthens tendons, dispels coldness, and removes hu-
midity. The function of this prescription was to tonify
the kidney and promote blood circulation.
Our findings indicate that BHF reduced IL-1β and
MMP-1 levels in the synovial fluid of joints, inhibited
DDR2 expression in chondrocytes, and lowered expres-
sion of MMP-1. BHF had no obvious effect on reduc-
tion of serum IL-1β levels. However, it significantly re-
duced IL-1β and MMP-1 levels in synovial fluid. This
would suggest a specific effect of BHF on synovial
cells. BHF reduced IL-1β levels in synovial fluid, there-
fore the functions of this cytokine were diminished.
This led to down-regulated expression of MMP-1
mRNA, decreased synthesis of chondrocytes and syno-
vial cells, and reduced secretion of PGE2. Lower PGE2
levels ameliorated destruction of cartilage and reduced
the generation of collagen fragments (DDR2 ligands).
The DDR2 signaling molecule could be inhibited by
BHF, and a reduction in DDR2, DDR2 ligand, and
IL-1β levels could be sequentially reached through
BHF treatment. Our RT-PCR results showed that re-
duced DDR2 and IL-1β levels led to reduced expres-
sion levels of MMP-1. Pathologically, BHF treatment
maintained cartilage integrity and thickness.
Patients with mild OA of the knee are treated through
body weight control, physical therapy and oral medica-
Li NH et al. / Experimental Study
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IL-1 fluid (ng/mL)
IL-1 sera (ng/mL)
DDR2（IOD value）
MMP-1 protein (μg/mL)
BHF
4.13±0.21a
7.39±5.35
15.24±2.19b
0.53±0.09a
GS
4.54±0.69a
8.35±5.27
21.90±5.31
0.63±0.08
Control
5.33±0.17
7.89±5.03
27.60±3.87
1.04±0.11
Table 1 Levels of IL-1β, MMP-1 and DDR2 in different groups (n = 11, xˉ ± s)
Notes: control group was treated with 2 mL of starch suspension gavaged for 6 weeks twice a day; glucosamine sulfate treatment group was
treated with 22 mg of glucosamine sulfate suspension gavaged twice a day for 6 weeks; Bushenhuoxue formula treatment group was treated
with 2 mL suspension of Bushenhuoxue formula decoction suspention gavaed twice a day for 6 weeks. BHF: Bushenhuoxue formula; GS:
glucosamine sulfate; IL-1β: interleukin-1 beta; DDR2: discoidin domain receptor 2; MMP-1:matrix metalloproteinase-1. For synovial flu-
id, IL-1β levels in samples from the BHF and GS treatment groups were significantly lower than those in the control group (P < 0.01).
There was no significant difference between the BHF and GS groups (P > 0.05). For serum IL-1β levels, there was no significant differ-
ence among the three groups (P > 0.05). DDR2 levels in cartilage for the BHF group were significantly different compared with those in
the control group (P = 0.03). MMP-1 levels in synovial fluid were significantly lower in BHF groups compared with those in the control
group (P < 0.01). aP < 0.01, bP < 0.05.
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Figure 3 Analysis of MMP-1 expression by RT-PCR
A: 1: control group; 2: glucosamine sulfate (GS) treatment
group; 3: Bushenhuoxue formula (BHF) treatment group. B:
gene expression profile of MMP-1 following treatment with
Bushenhuoxue formula and glucosamine sulfate for 6 weeks.
Control group was treated with 2 mL of starch suspension
gavaged for 6 weeks twice a day; glucosamine sulfate treat-
ment group was treated with 22 mg of glucosamine sulfate
suspension gavaged twice a day for 6 weeks; Bushenhuoxue
formula treatment group was treated with 2 mL suspen-
sion of Bushenhuoxue formula decoction suspention ga-
vaed twice a day for 6 weeks. MMP-1: matrix metalloprotein-
ase-1; RT-PCR: reverse transcription polymerase chain reac-
tion. MMP-1 expression levels in the Bushenhuoxue formula
group were significantly decreased compared with those in
the control group (P < 0.05).
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tion.8 The most commonly used drugs are cartilage pro-
tective agents and non-steroidal anti-inflammatory an-
algesics to relieve pain. GS has been widely used9 with
a satisfactory clinical efficacy, but its biological mecha-
nism remains unclear.10 Some researchers believe that
the effects of glucosamine hydrochloride are similar to
those for GS. Other researchers11 found that glucos-
amine hydrochloride should be combined with other
drugs to be used clinically for treating OA as no signifi-
cant effects were observed when it was used alone.
Some studies have suggested that GS might affect in-
ducible nitric oxide synthase.12 According to our re-
sults, GS has some effect on reducing IL-1β levels in
synovial fluid.
It is difficult to determine which compound(s) in a
Chinese herb plays a major pharmacological role in the
treatment of pathological disorders. The method of kid-
ney tonifying and blood platelet activation has been re-
ported as an optional regimen in treating OA.13 Howev-
er, current prescriptions differ completely from our for-
mulation. Further investigation is required to explore
the specific therapeutic component(s) in our formula
and its mechanism(s) of action.
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